A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Genomic Medicine XIV: Genomic Learning Healthcare Systems
Wednesday, August 31 – Thursday, September 1, 2022 | 11 a.m. – 5 p.m. ET | Virtual
On August 31 – September 1, 2022, the National Human Genome Research Institute (NHGRI) will sponsor its 14th Genomic Medicine meeting, Genomic Medicine XIV: Genomic Learning Healthcare Systems.
This meeting will discuss progress and identify generalizable solutions to the challenges of implementing genomic medicine we have encountered since the 2015 National Academy of Medicine’s Genomics-Enabled Learning Health Care Systems workshop. Persistent barriers and evidence gaps will be examined as opportunities for additional research.
GMKB